Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Usability of Ciprofloxacin DPI in NCFB or COPD
NCT02661438Completed
- Sponsor
- Bayer
- Start
- Jan 2016
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ciprofloxacin in Non-Cystic Fibrosis Bronchiectasis (NCFB), sponsored by Bayer. Primary endpoints: The user performed the inhalation task based on the given instructions properly at 1 day, The user performed the inhalation task safely at 1 day and 2 more. Started Jan 2016; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
Non-Cystic Fibrosis Bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT02661438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02661438.